1449668-98-7

Basic information

• Product Name: C₁₇H₁₈N₄O₂
• Synonyms: C₁₇H₁₈N₄O₂
• CAS NO: 1449668-98-7
• Molecular Weight: 310.356
• Mol File: 1449668-98-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₁₇H₁₈N₄O₂(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₇H₁₈N₄O₂(1449668-98-7)
• EPA Substance Registry System: C₁₇H₁₈N₄O₂(1449668-98-7)

Safety Data

• Hazardous Substances Data: 1449668-98-7(Hazardous Substances Data)

Upstream product

• 607373-83-1 2-chloro-4-methoxy-5-nitro-pyridine 
• 1449506-71-1 (2-chloro-5-nitro-pyridin-4-yl)-methyl-amine 
• 87034-76-2 6-chloro-N⁴-methylpyridine-3,4-diamine 
• 4748-80-5 4-ethyl-3-nitro-benzaldehyde 
• 103440-95-5 4-Ethyl-3-nitrobenzoic acid 
• 24812-93-9 3-amino-4-ethylbenzoic acid methyl ester 
• 7205-46-1 6-chloro-1-methyl-1H-imidazo[4,5-c]pyridine 
• 51885-79-1 4-ethyl-3-nitro-benzoic acid methyl ester 

Relevant articles and documents

IMIDAZO [4, 5 -C] PYRIDINE DERIVATIVES USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES

Novel imidazolopyridines according to Formula I, able to inhibit JAK are disclosed, wherein R1 and Cy are as disclosed herein. These compounds may be prepared as a pharmaceutical composition, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, allergic or inflammatory conditions, autoimmune diseases, proliferative diseases, transplantation rejection, diseases involving impairment of cartilage turnover, congenital cartilage malformations, and/or diseases associated with hypersecretion of IL6 or interferons.